
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
It is indicated for glycemic control in adults with type 2 diabetes mellitus and may reduce the risk of major adverse cardiovascular events in high-risk patients.【more】
Article source:Captain MedicineRelease date:2026-10-21Recommended:3
A therapy for the treatment of adult and pediatric patients aged 2 years and older with NF1-PN.【more】
Article source:Captain MedicineRelease date:2026-10-21Recommended:4
For the treatment of hypertension in adult patients.【more】
Article source:Captain MedicineRelease date:2026-10-21Recommended:4
Indicated for the treatment of intermediate- or high-risk myelofibrosis in adults, polycythemia vera in patients with an inadequate response to hydroxyurea, and steroid-refractory ···【more】
Article source:Captain MedicineRelease date:2026-10-21Recommended:3
Indicated for the prevention of cytomegalovirus infection and disease, primarily in adult and pediatric patients at high risk following hematopoietic stem cell transplantation or k···【more】
Article source:Captain MedicineRelease date:2026-10-21Recommended:3
Indicated for the treatment of multidrug-resistant pulmonary tuberculosis in adults, to be used in combination with bedaquiline and linezolid.【more】
Article source:Captain MedicineRelease date:2026-10-21Recommended:3
Indicated for the treatment of primary biliary cholangitis (PBC) in adults who have an inadequate response to or are intolerant of ursodeoxycholic acid.【more】
Article source:Captain MedicineRelease date:2026-10-21Recommended:3
Indicated for the treatment of adult and pediatric patients 12 years of age and older with Grade 2 astrocytoma or oligodendroglioma harboring an IDH1 or IDH2 mutation as detected b···【more】
Article source:Captain MedicineRelease date:2026-10-21Recommended:4
Indicated for the treatment of unresectable, locally advanced or metastatic, symptomatic or progressive medullary thyroid cancer (MTC).【more】
Article source:Captain MedicineRelease date:2026-10-21Recommended:3
Indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults and pediatric patients 6 years of age and older weighing at least 25 kg with compensated liver di···【more】
Article source:Captain MedicineRelease date:2026-10-21Recommended:4
Indicated for the treatment of unresectable hepatocellular carcinoma, advanced renal cell carcinoma, and progressive differentiated thyroid cancer that is refractory to radioactive···【more】
Article source:Captain MedicineRelease date:2026-10-21Recommended:3
Indicated for the treatment of hyperlipidemia associated with elevated triglycerides.【more】
Article source:Captain MedicineRelease date:2026-10-21Recommended:4
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:8542025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:10512024-09-07
Recently, Lao Lucius Pharmaceutical (Lucius Pharmaceuticals) issued a solemn statement regarding cou···【more】
Recommended:3152026-10-10
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended:4072026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended:6012026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended:5772026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended:4602026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended:6122026-31-07

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643